Franklin FTSE Taiwan UCITS ETF EUR is a equity ETF from Franklin Templeton tracking the FTSE Taiwan index through physical replication. Domiciled in Ireland and launched in 2022, the fund manages about 557 M € and charges a TER of 0.19% — 19 € per year on a €10,000 investment. Income is automatically reinvested in the fund (accumulating).
Franklin FTSE Taiwan UCITS ETF EUR competes with 175 other products in the same class and region (Equity, Global): it ranks 64th by fund size and 13th by ongoing cost, with a TER of 0.19% against a group median of 0.40%. It has been listed since 2022, 4 years of track record.
On a €10,000 investment the TER costs 19 € a year, against 40 € for the median product in the category.
Replication is physical: the fund holds the underlying securities directly. The ten largest positions account for 59.4% of the portfolio.
Income is accumulated: no distribution is paid out, the share price absorbs it. In a savings plan this removes the need to reinvest dividends by hand. The fund is denominated in EUR. That is not the same as currency risk: the exposure comes from the currencies of the underlying holdings, not from the denomination or the trading currency of a given listing.
Irish domicile lets the fund apply the Ireland–US tax treaty, with 15% withholding instead of 30% on US dividends received by the fund.
| Taiwan Semiconductor Manufacturing Co. Ltd. | 29.8% |
| MediaTek Inc | 8.0% |
| Delta Electronics Inc | 4.8% |
| Hon Hai Precision Industry Co Ltd | 3.9% |
| ASE Industrial Holding Co Ltd | 2.9% |
| United Microelectronics Corporation | 2.5% |
| Yageo Corp | 2.2% |
| Elite Material Co Ltd | 2.0% |
| Unimicron Technology Corp | 1.7% |
| CTBC Financial Holding Co Ltd | 1.6% |
| Borsa Italiana | FLXT | EUR |
| XETRA | FLXT | EUR |
| London Stock Exchange | FLXT | USD |
| London Stock Exchange | FRXT | GBP |
| Euronext Paris | FLXT | EUR |
Source: the fund's KID and the issuer's official documentation — data verified as of July 2026.
This page is informational and is not an investment recommendation. Figures may contain errors or be out of date: always check the KID and the issuer's factsheet before any decision.